Additional file 1 of Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer

Additional file 1: Table S1. List of primers for qRT-PCR. Table S2. The list of human E3 ligases. Table S3. The differential expressing E3 ligase genes between the prostate cancer and normal prostate. Table S4. The analysis of clinical characteristics and the expression of CDC20 by immunohistochemistry. Table S5. The differential expressing genes between the CDC20-low and CDC20-high group. Table S6. List of FACS antibodies. Table S7. Detailed information of datasets used in this study. Table S8. The high confidence results (Core) and CDC20 Expression from TIDE analysis.